[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.92.62. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 410
Citations 0
Correction
February 2013

Error in Table in: Reactivation of Retinopathy of Prematurity After Bevacizumab Injection

JAMA Ophthalmol. 2013;131(2):212. doi:10.1001/jamaophthalmol.2013.1984

Error in Table. In the Clinical Sciences article titled “Reactivation of Retinopathy of Prematurity After Bevacizumab Injection” by Hu et al, published in the August 2012 issue of the journal (2012;130[8]:1000-1006), an error occurred in Table 1. For patient 1, the postmenstrual age at recurrence should have been 49 weeks, not 149 weeks.

×